The neuropeptide substance P is found in perivascular and free unmyelinated nerve fibres in human synovial tissue. Quantitative receptor autoradiography was used to show specific, high affinity (Kd=0-75 (0-21), nmol/l (mean (standard error of the mean)), low capacity (Bmax=27-8 (7.9) amol/mm2) binding sites for substance P Bolton Hunter-labelled with iodine-125 localised to vascular endothelial cells in human synovial tissue. The binding could be saturated, was reversible, and was dependent on the magnesium concentration. Unlabelled substance P and neurokinin A competitively inhibited specific binding with 50% inhibition at concentrations of 1-25 (0.21) and 175 (29) 
The nervous system has been implicated in the aetiology and pathogenesis of human joint disease.' 2 Neurological lesions such as strokes and poliomyelitis are protective against rheumatoid arthritis3 4 and osteoarthritis5 in the affected limbs. In contrast, complete sensory denervation can lead to a severe, destructive Charcot's arthropathy. 6 Similarly, neurological lesions in animals influence the development and severity of experimentally induced arthritis. 7 The human nervous system has been clearly shown to modulate inflammatory processes in peripheral tissues and to influence each of the classical signs of inflammation: rubor, calor, tumour, and dolor. 8 The effects of the sympathetic nervous system on vascular tone are well recognised. In addition, unmyelinated sensory fibres contain neuropeptides such as substance P, which may be released centrally to participate in pain pathways, and peripherally where it may modulate vascular function. 9 There is increasing evidence that substance P can be released into joints from peripheral nerve terminals and may therefore influence the course of joint disease. Nerves containing substance P are associated with blood vessels and occur as free fibres in human synovial tissue. 10 I I Antidromic stimulation of the articular nerve in the knee of cats results in the release of substance P-like immunoreactivity into the joint,'2 vasodilatation and plasma extravasation,'3 and substance P-like immunoreactivity has been detected in human synovial fluid, suggesting that the local release of the peptide also occurs in human joints.4 15 Depletion of nerves containing substance P in rats, by neonatal treatment with the sensory neurotoxin capsaicin, reduces the severity of subsequently induced adjuvant arthritis in the adult animal,7 whereas intra-articular injection of substance P increases its severity,'6 suggesting a possible part for substance P in the pathogenesis of at least this form of arthritis.
Substance P is a member of the tachykinin family of peptides which also includes the closely related molecules neurokinin A and neurokinin B. Its peripheral actions may result from direct effects on vascular tissue such as the release of endothelium derived relaxing factor (nitric oxide) from endothelial cells, '7 (7 9) amol/mm2 respectively. IC) and synovium from normal control subjects ( fig ID) . 
Discussion
We have shown specific, high affinity, low capacity binding sites for '25I-BH-SP on endothelial cells of human synovial blood vessels. 
